It is with deep sorrow that the American Society for Dermatologic Surgery announces the passing of Alastair Carruthers, FRCPC, a pioneering physician and esteemed member of the medical community whose contributions left an indelible mark on the field of Dermatology. He was an innovator with a collaborative spirit matched only by his love of his family and kindness towards his mentees.
Alongside his wife, Dr. Jean Carruthers, Alastair led the discovery of the cosmetic use of botulinum toxin A, a significant advancement in dermatologic treatment. BOTOX® was the first FDA-approved treatment of its kind – beginning with its 2002 approval for treating glabellar lines. The Carruthers are largely to credit for making BOTOX® a household name, and his passing leaves a deep void for many of his colleagues.
Alastair became the first Canadian President of the American Society for Dermatologic Surgery (ASDS) from 2006 to 2007. He was passionate about fostering the future of dermatologic surgery through education and engagement, establishing the First Annual ASDS Gala, the ASDS Stegman Circle fundraising initiative and the Society's advocacy arm, ASDSA, during his presidential tenure.
His leadership extended through his dedication to ASDS, where he served on 39 committees and work groups, held the role of ASDS Historian / Parliamentarian from 2012 to 2018 and led early-career dermatologists as a mentor for the ASDS Future Leaders Network program from 2017 to 2019. He was also an esteemed faculty member at many ASDS Annual Meetings and educational offerings. Throughout his career, Alastair published over 100 articles and authored several textbooks. These contributions were recognized with numerous honors, including the ASDS Samuel J. Stegman, MD, Award for Outstanding Service in 2010, the ASDS Leadership in Innovation Lectureship in 2014, and the ASDS President's Award in 2015.
Dr. Alastair Carruthers will be deeply missed by his family, colleagues and all who had the privilege of knowing him. His legacy of innovation, leadership and dedication will continue to inspire and impact the lives of many.